(Q37004734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Molecular prognostic factors in patients with pancreatic cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Francesco Pantano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bruno Vincenzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Roberto Coppola

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Daniele Santini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Armando Gabbrielli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

1553-1569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18020978%20AND%20SRC:MED&resulttype=core&format=json

Cancer burden in the year 2000. The global picture

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Tumour suppressor genes in disease and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Programmed cell death in animal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Regulation of apoptosis by Bcl‐2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Hypoxia, BNip3 proteins, and the mitochondrial death pathway in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

21 January 2018

Integrins and anoikis

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Syndecans in tumor cell adhesion and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Transcriptional regulation by extracellular signals: mechanisms and specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Signaling of transforming growth factor-beta family members through Smad proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Growth factors and their receptors in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

VEGF-RII influences the prognosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Prognostic significance of angiogenesis in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

A molecular gradient in early Drosophila embryos and its role in specifying the body pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Cloning and chromosome assignment of the human CDX2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

The clinical significance of MAGEA3 expression in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Skp2 contains a novel cyclin A binding domain that directly protects cyclin A from inhibition by p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

High-level Skp2 expression in pancreatic ductal adenocarcinoma: correlation with the extent of lymph node metastasis, higher histological grade, and poorer patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Genetics and biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553

Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.12.1553